Characterization of Vitreous and Aqueous Proteome in Humans With Proliferative Diabetic Retinopathy and Its Clinical Correlation

Overview

Journal Proteomics Insights

Publisher Sage Publications

Specialty Biochemistry

Date 2017 May 5

PMID 28469465

Citations 27

Authors

Sankarathi Balaiya

Zimei Zhou

Kakarla V Chalam

Affiliations

Soon will be listed here.

Abstract

Aims: Proliferative diabetic retinopathy (PDR) is associated with microvascular complications that cause biochemical changes in the human retina and alter the proteome of vitreous humor and aqueous humor (AH).

Methods: Human vitreous humor and AH of PDR subjects were collected. Subjects who had surgery for epiretinal membrane or macular hole served as controls. Protein profiles were obtained and analyzed after running the samples on a liquid chromatography-mass spectrometry/mass spectrometry.

Results: In vitreous humor, 16 unique proteins were noted in PDR patients, but not in controls. Those were associated mainly with coagulation, complement, and kallikrein-kinin systems. Under coagulation, fibrinogen and prothrombin proteins were more evident and may emphasize the importance of angiogenesis in the development of PDR. Vitreous proteins showed replicative presence in AH too. As for AH samples, we detected 10 proteins found in PDR patients, which were related to transport, coagulation, and inflammatory responses.

Conclusions: We found 57 proteins in human vitreous and 39 proteins in AH. Identification of these proteins that are involved in various pathways will be helpful to understand diabetic retinopathy pathogenesis and to develop proteome as a biomarker for PDR.

Citing Articles

Clinical serum lipidomic profiling revealed potential lipid biomarkers for early diabetic retinopathy.

Sun W, Su M, Zhuang L, Ding Y, Zhang Q, Lyu D Sci Rep. 2024; 14(1):15148.

PMID: 38956223 PMC: 11219800. DOI: 10.1038/s41598-024-66157-z.

Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases.

Titz B, Siebourg-Polster J, Bartolo F, Lavergne V, Jiang Z, Gayan J Transl Vis Sci Technol. 2024; 13(6):17.

PMID: 38913008 PMC: 11205237. DOI: 10.1167/tvst.13.6.17.

A Look into Ocular Diseases: The Pivotal Role of Omics Sciences in Ophthalmology Research.

Fucito M, Spedicato M, Felletti S, Yu A, Busin M, Pasti L ACS Meas Sci Au. 2024; 4(3):247-259.

PMID: 38910860 PMC: 11191728. DOI: 10.1021/acsmeasuresciau.3c00067.

Biochemical Changes in Anterior Chamber of the Eye in Diabetic Patients-A Review.

Dolar-Szczasny J, Drab A, Rejdak R J Clin Med. 2024; 13(9).

PMID: 38731110 PMC: 11084197. DOI: 10.3390/jcm13092581.

Tandem Mass Tag LC-MS/MS of Aqueous Humor From Individuals With Type 2 Diabetes Without Retinopathy Reveals Early Dysregulation of Synaptic Proteins.

Sachdeva M, Lee Y, Unlu E, Koseoglu N, Cha E, Wang J Invest Ophthalmol Vis Sci. 2024; 65(3):16.

PMID: 38470329 PMC: 10939138. DOI: 10.1167/iovs.65.3.16.

References

den Hollander A, McGee T, Ziviello C, Banfi S, Dryja T, Gonzalez-Fernandez F . A homozygous missense mutation in the IRBP gene (RBP3) associated with autosomal recessive retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2008; 50(4):1864-72. PMC: 2823395. DOI: 10.1167/iovs.08-2497. View

Lewis E . Expanding the clinical indications for α(1)-antitrypsin therapy. Mol Med. 2012; 18:957-70. PMC: 3459478. DOI: 10.2119/molmed.2011.00196. View

Krentz A, Clough G, Byrne C . Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications. Diabetes Obes Metab. 2007; 9(6):781-91. DOI: 10.1111/j.1463-1326.2007.00670.x. View

Murthy K, Goel R, Subbannayya Y, Jacob H, Murthy P, Manda S . Proteomic analysis of human vitreous humor. Clin Proteomics. 2014; 11(1):29. PMC: 4106660. DOI: 10.1186/1559-0275-11-29. View

Funatsu H, Yamashita H, Nakanishi Y, Hori S . Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy. Br J Ophthalmol. 2002; 86(3):311-5. PMC: 1771054. DOI: 10.1136/bjo.86.3.311. View

Kolodziejczyk J, Ponczek M . The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression. Contemp Oncol (Pozn). 2013; 17(2):113-9. PMC: 3685376. DOI: 10.5114/wo.2013.34611. View

Rocha A, Santos F, Monteiro J, Castro-de-Sousa J, Queiroz J, Tomaz C . Trends in proteomic analysis of human vitreous humor samples. Electrophoresis. 2014; 35(17):2495-508. DOI: 10.1002/elps.201400049. View

Kim J, Kim J, Jun H, Yu Y, Min B, Park K . Protective effect of clusterin from oxidative stress-induced apoptosis in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2009; 51(1):561-6. DOI: 10.1167/iovs.09-3774. View

Hernandez C, Garcia-Ramirez M, Simo R . Overexpression of hemopexin in the diabetic eye: a new pathogenic candidate for diabetic macular edema. Diabetes Care. 2013; 36(9):2815-21. PMC: 3747892. DOI: 10.2337/dc12-2634. View

10.

Ramesh S, Bonshek R, Bishop P . Immunolocalisation of opticin in the human eye. Br J Ophthalmol. 2004; 88(5):697-702. PMC: 1772128. DOI: 10.1136/bjo.2003.031989. View

11.

Marciniak K, Butwicka A, Nowak J . [PEDF: an endogenous factor displaying potent neuroprotective, neurotrophic, and antiangiogenic activity]. Postepy Hig Med Dosw (Online). 2006; 60:387-96. View

12.

Al-Latayfeh M, Silva P, Sun J, Aiello L . Antiangiogenic therapy for ischemic retinopathies. Cold Spring Harb Perspect Med. 2012; 2(6):a006411. PMC: 3367538. DOI: 10.1101/cshperspect.a006411. View

13.

Jackson J, Gleave M, Gleave J, Burt H . The inhibition of angiogenesis by antisense oligonucleotides to clusterin. Angiogenesis. 2005; 8(3):229-38. DOI: 10.1007/s10456-005-9018-5. View

14.

Feener E . Plasma kallikrein and diabetic macular edema. Curr Diab Rep. 2010; 10(4):270-5. DOI: 10.1007/s11892-010-0127-1. View

15.

Skeie J, Brown E, Martinez H, Russell S, Birkholz E, Folk J . Proteomic analysis of vitreous biopsy techniques. Retina. 2012; 32(10):2141-9. PMC: 3637028. DOI: 10.1097/IAE.0b013e3182562017. View

16.

Kim J, Kim J, Yu Y, Min B, Kim K . Protective effect of clusterin on blood-retinal barrier breakdown in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2009; 51(3):1659-65. DOI: 10.1167/iovs.09-3615. View

17.

Tomic M, Ljubic S, Kastelan S . The role of inflammation and endothelial dysfunction in the pathogenesis of diabetic retinopathy. Coll Antropol. 2013; 37 Suppl 1:51-7. View

18.

Freddo T . A contemporary concept of the blood-aqueous barrier. Prog Retin Eye Res. 2012; 32:181-95. PMC: 3544162. DOI: 10.1016/j.preteyeres.2012.10.004. View

19.

Azad N, Agrawal L, Emanuele N, Klein R, Bahn G, McCarren M . Association of PAI-1 and fibrinogen with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care. 2013; 37(2):501-6. PMC: 3898766. DOI: 10.2337/dc13-1193. View

20.

Simo R, Hernandez C . Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives. Trends Endocrinol Metab. 2013; 25(1):23-33. DOI: 10.1016/j.tem.2013.09.005. View